Annual Cash & Cash Equivalents
$221.75 M
+$108.75 M+96.23%
December 31, 2023
Summary
- As of February 22, 2025, BLUE annual cash & cash equivalents is $221.75 million, with the most recent change of +$108.75 million (+96.23%) on December 31, 2023.
- During the last 3 years, BLUE annual cash & cash equivalents has fallen by -$38.87 million (-14.92%).
- BLUE annual cash & cash equivalents is now -70.76% below its all-time high of $758.50 million, reached on December 31, 2017.
Performance
BLUE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$70.65 M
-$73.42 M-50.96%
September 30, 2024
Summary
- As of February 22, 2025, BLUE quarterly cash and cash equivalents is $70.65 million, with the most recent change of -$73.42 million (-50.96%) on September 30, 2024.
- Over the past year, BLUE quarterly cash and cash equivalents has dropped by -$141.40 million (-66.68%).
- BLUE quarterly cash and cash equivalents is now -94.11% below its all-time high of $1.20 billion, reached on June 30, 2020.
Performance
BLUE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BLUE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +96.2% | -66.7% |
| 3 y3 years | -14.9% | -37.5% |
| 5 y5 years | -44.9% | -76.5% |
BLUE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.2% | -70.4% | +6.3% |
| 5 y | 5-year | -32.2% | +96.2% | -94.1% | +6.3% |
| alltime | all time | -70.8% | +766.1% | -94.1% | +6.3% |
Bluebird Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $70.65 M(-51.0%) |
| Jun 2024 | - | $144.07 M(-32.1%) |
| Mar 2024 | - | $212.05 M(-4.4%) |
| Dec 2023 | $221.75 M(+96.2%) | $221.75 M(+34.1%) |
| Sep 2023 | - | $165.35 M(-4.4%) |
| Jun 2023 | - | $172.87 M(-27.7%) |
| Mar 2023 | - | $239.04 M(+111.5%) |
| Dec 2022 | $113.01 M(-29.9%) | $113.01 M(+70.0%) |
| Sep 2022 | - | $66.48 M(-18.4%) |
| Jun 2022 | - | $81.50 M(-23.3%) |
| Mar 2022 | - | $106.26 M(-34.1%) |
| Dec 2021 | $161.16 M(-38.2%) | $161.16 M(-60.0%) |
| Sep 2021 | - | $402.46 M(+13.9%) |
| Jun 2021 | - | $353.47 M(-19.6%) |
| Mar 2021 | - | $439.71 M(+68.7%) |
| Dec 2020 | $260.63 M(-20.3%) | $260.63 M(-19.6%) |
| Sep 2020 | - | $324.16 M(-73.0%) |
| Jun 2020 | - | $1.20 B(+245.8%) |
| Mar 2020 | - | $346.63 M(+5.9%) |
| Dec 2019 | $327.21 M(-18.7%) | $327.21 M(+8.9%) |
| Sep 2019 | - | $300.43 M(+6.9%) |
| Jun 2019 | - | $281.00 M(+26.7%) |
| Mar 2019 | - | $221.74 M(-44.9%) |
| Dec 2018 | $402.58 M | $402.58 M(-57.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $952.14 M(+185.1%) |
| Jun 2018 | - | $333.95 M(-26.9%) |
| Mar 2018 | - | $456.54 M(-39.8%) |
| Dec 2017 | $758.50 M(+172.0%) | $758.50 M(+218.8%) |
| Sep 2017 | - | $237.96 M(-65.3%) |
| Jun 2017 | - | $686.33 M(+217.7%) |
| Mar 2017 | - | $216.00 M(-22.5%) |
| Dec 2016 | $278.89 M(+69.8%) | $278.89 M(+13.8%) |
| Sep 2016 | - | $245.15 M(+10.1%) |
| Jun 2016 | - | $222.63 M(+15.6%) |
| Mar 2016 | - | $192.59 M(+17.2%) |
| Dec 2015 | $164.27 M(-52.8%) | $164.27 M(-60.7%) |
| Sep 2015 | - | $417.51 M(-29.6%) |
| Jun 2015 | - | $593.30 M(+345.5%) |
| Mar 2015 | - | $133.17 M(-61.7%) |
| Dec 2014 | $347.85 M(+68.6%) | $347.85 M(+288.2%) |
| Sep 2014 | - | $89.60 M(-49.0%) |
| Jun 2014 | - | $175.71 M(-8.7%) |
| Mar 2014 | - | $192.50 M(-6.7%) |
| Dec 2013 | $206.28 M(+207.8%) | $206.28 M(-4.8%) |
| Sep 2013 | - | $216.79 M(-5.3%) |
| Jun 2013 | - | $228.85 M(+73.6%) |
| Mar 2013 | - | $131.84 M(+96.7%) |
| Dec 2012 | $67.01 M(+161.7%) | $67.01 M |
| Dec 2011 | $25.60 M | - |
FAQ
- What is bluebird bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for bluebird bio?
- What is bluebird bio annual cash & cash equivalents year-on-year change?
- What is bluebird bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for bluebird bio?
- What is bluebird bio quarterly cash and cash equivalents year-on-year change?
What is bluebird bio annual cash & cash equivalents?
The current annual cash & cash equivalents of BLUE is $221.75 M
What is the all time high annual cash & cash equivalents for bluebird bio?
bluebird bio all-time high annual cash & cash equivalents is $758.50 M
What is bluebird bio annual cash & cash equivalents year-on-year change?
Over the past year, BLUE annual cash & cash equivalents has changed by +$108.75 M (+96.23%)
What is bluebird bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BLUE is $70.65 M
What is the all time high quarterly cash and cash equivalents for bluebird bio?
bluebird bio all-time high quarterly cash and cash equivalents is $1.20 B
What is bluebird bio quarterly cash and cash equivalents year-on-year change?
Over the past year, BLUE quarterly cash and cash equivalents has changed by -$141.40 M (-66.68%)